Clinical trials
Recruiting Phase 1/2 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 14 |
| 2023 | 5 |
| 2024 | 12 |
| 2025 | 12 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 11 |
| Fred Hutchinson Cancer Center | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | 2 |
| Essen Biotech | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| AB Science | 1 |
| ARCE Therapeutics, Inc. | 1 |
| Advanced BioDesign | 1 |
| Aptose Biosciences Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 74 |
| Myelodysplastic Syndromes | 18 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 12 |
| Hematologic Neoplasms | 9 |
| Leukemia, Biphenotypic, Acute | 9 |
| Leukemia, Myelomonocytic, Chronic | 7 |
| Multiple Myeloma | 6 |
| Anemia, Refractory, with Excess of Blasts | 5 |
| Lymphoma | 5 |
| Recurrence | 5 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.